Encompass Health CorpEHC
▲ PositiveCapitalrelevance
Q2 earnings and revenue beat, raised guidance

Encompass Health reported better-than-expected second-quarter CY2026 results, with revenue rising 9.6% year on year to $1.60 billion, beating analyst estimates of $1.57 billion. Adjusted earnings per share came in at $1.55, surpassing the consensus estimate of $1.48 by 4.7%, while adjusted EBITDA of $348 million also topped expectations. The company raised its full-year revenue guidance to $6.45 billion at the midpoint from $6.42 billion and lifted its full-year adjusted EPS guidance to $6.14, a 2.2% increase. Same-store sales grew 2.8% year on year, and the stock jumped 7.6% to $119.19 following the announcement.
Encompass Health CorpQ2 earnings and revenue beat, raised guidance